The UK High Court of Justice (Patents Court) refused to grant Regen Lab SA (Regenlab) permission to appeal the finding that its European PRP patent is invalid.
This UK judgment along with the Patents Court’s refusal to grant permission to appeal add to the German court’s decision dismissing the Regenlab infringement claim, the European Patent Office two preliminary opinions which found the same Regenlab patent to be invalid on multiple grounds, and the venue judgment in New York in which Regen Lab lost its case against Estar Medical.
